Showing results (1-10 of 757) with videos related to
Sort By:
Pageof 76
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
Spheramine Titan/ScheringDonald Grosset, Katherine GrossetIdrugs : the Investigational Drugs Journal|August 20, 2010
The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement DisordersDonald Grosset, Andrew GrossetMovement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Trial of subtherapeutic pergolide in de novo Parkinson's diseaseKatherine Grosset, Donald Grosset, Andrew Lees, et al.BMC Neurology|July 20, 2007
Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trialKatherine A Grosset, Donald G GrossetMovement Disorders : Official Journal of the Movement Disorder Society|February 19, 2005
Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of lifeKatherine A Grosset, Donald G GrossetAnnals of Clinical Biochemistry|June 28, 2007
Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolitesD F Davidson, K Grosset, D GrossetLa Revue Du Praticien|March 11, 1990
[Bacteriologic basis for the treatment of tuberculosis]J GrossetJournal of the Neurological Sciences|October 2, 2009
Therapy adherence issues in Parkinson's diseaseDonald Grosset, Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion tableKatherine Grosset, Fiona Needleman, Graeme Macphee, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2005
Suboptimal medication adherence in Parkinson's diseaseKatherine A Grosset, Ian Bone, Donald G GrossetPageof 76